# IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency

> **NCT07686692** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Duke University** · enrollment: 300 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction
- Iron Deficiency

## Interventions

- **DRUG:** Ferric derisomaltose
- **DRUG:** Placebo (normal saline)

## Key facts

- **NCT ID:** NCT07686692
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2030-08
- **Final completion:** 2030-08
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-07-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07686692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07686692, "IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07686692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*